首页 › 基金 › Artia Global Partners LP › DNA
Artia Global Partners LP 对 DNA 的持仓历史
GINKGO BIOWORKS HOLDINGS INC · 医疗保健
Artia Global Partners LP 在 Q3 2026 的 13F 申报中披露持有 DNA(GINKGO BIOWORKS HOLDINGS INC)20,444 股,市值约 US$262K,约占其申报组合的 0.05%,在其申报持仓中市值排名第 50 位。 Artia Global Partners LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Artia Global Partners LP 对 DNA 的持仓演变
Artia Global Partners LP 于 Q3 2026 首次披露 DNA 持仓:20,444 股(约 US$262K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 20.44K | $262.30K | 新进 |
关于 DNA 与 13F 数据
DNA(GINKGO BIOWORKS HOLDINGS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 DNA,申报仓位最大的包括:Anchorage Capital Group, L.L.C. (US$17.3M), FORBES J M & CO LLP (US$12.5M), SB INVESTMENT ADVISERS (UK) LTD (US$6.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DNA 的基金
- Anchorage Capital Group, L.L.C. 1.75M 股 · $17.31M · Q2 2026
- FORBES J M & CO LLP 977.37K 股 · $12.54M · Q3 2026
- SB INVESTMENT ADVISERS (UK) LTD 610.73K 股 · $6.05M · Q2 2026
更多关于 Artia Global Partners LP
常见问题
How long has Artia Global Partners LP held DNA?
Artia Global Partners LP has disclosed DNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Artia Global Partners LP's current position in DNA?
As of Q3 2026, Artia Global Partners LP holds 20.44K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $262.30K, representing 0.05% of its reported portfolio and ranking #50.
Has Artia Global Partners LP been buying or selling DNA?
In the latest 13F filing (Q3 2026), Artia Global Partners LP newly opened its position in DNA.
Which other funds hold DNA?
Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, SB INVESTMENT ADVISERS (UK) LTD, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.